Remove 2004 Remove Healthcare Remove Leads
article thumbnail

Lung cancer deaths decline but.

World of DTC Marketing

In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017. But it’s still the leading cause of cancer deaths. Although lung cancer’s mortality rate has fallen, the disease is still the leading cause of cancer deaths.

Medicine 271
article thumbnail

European Commission revokes marketing authorisation for Novartis’ crizanlizumab

European Pharmaceutical Review

Novartis said the decision to revoke the authorisation was based on a review of crizanlizumab under Article 20 of Regulation (EC) No 726/2004. EMA required the STAND study as part of the marketing authorisation.

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

2 Approach taken by regulators in the UK The Medicines and Healthcare products Regulatory Agency regulates herbal medicines in the UK. 10 Directive 2004/24/EC introduced a registration scheme for traditional herbal medicines and requires herbal remedies sold over the counter in the UK to be registered. 2012/1916). Ethnopharmacol.

Marketing 103
article thumbnail

New Bill could enhance UK clinical trial regulation

European Pharmaceutical Review

If achieved, this would boost the UK’s competitiveness as a leading international site for trials. This activity should bring together relevant data sets which are collected by both the Medicines and Healthcare products Regulatory Agency (MHRA) and HRA. Mansfield also listed the main elements of The Future Clinical Trials Bill.

Ethics 105
article thumbnail

Realising milestones with gene therapy for SMA

European Pharmaceutical Review

percent of Europe’s annual healthcare spend. In 2015, she joined Astellas Pharma, Northbrook, IL, and served as Global Lead for Immunology, CNS and Neuromuscular Indications and eventually as Global Medical Lead for the Muscle TA. Stakeholder education is critical to achieving this.

article thumbnail

New Prescription Migraine Drugs Aren’t Resonating with Patients—Here’s How Pharma Can Boost Uptake

PM360

However, the good news is that patients are asking their doctors for help—76% of surveyed patients reported having talked with their healthcare providers about migraine treatment options, and within that group, 64% and 54% discussed acute medications and preventive treatments, respectively. What Marketers Can Do.

article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

border healthcare, specifically by repealing Article 15, which originally laid down the modalities and principles for co-operation between Member States in assessing new health technologies. governmental healthcare organisations. Vincenzo Salvatore is of counsel and leader of the Healthcare and Life Sciences Focus Team at BonelliErede.